A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells

Abstract

Background Type I interferons (IFN-I) are key responders to central nervous system infection and injury and are also increased in common neurodegenerative diseases. Their effects are primarily mediated via transcriptional regulation of several hundred interferon-regulated genes. In addition, IFN-I activate several kinases including members of the MAPK and PI3K families. Yet, how changes to the global protein phosphoproteome contribute to the cellular response to IFN-I is unknown. Methods The cerebral phosphoproteome of mice with brain-targeted chronic production of the IFN-I, IFN-α, was obtained. Changes in phosphorylation were analyzed by ontology and pathway analysis and kinase enrichment predictions. These were verified by phenotypic analysis, immunohistochemistry and immunoblots. In addition, primary murine microglia and astrocytes, the brain's primary IFN-I-responding cells, were acutely treated with IFN-α and the global phosphoproteome was similarly analyzed. Results We identified widespread protein phosphorylation as a novel mechanism by which IFN-I mediate their effects. In our mouse model for IFN-I-induced neurodegeneration, protein phosphorylation, rather than the proteome, aligned with the clinical hallmarks and pathological outcome, including impaired development, motor dysfunction and seizures. In vitro experiments revealed extensive and rapid IFN-I-induced protein phosphorylation in microglia and astrocytes. Response to acute IFN-I stimulation was independent of gene expression and mediated by a small number of kinase families. The changes in the phosphoproteome affected a diverse range of cellular processes and functional analysis suggested that this response induced an immediate reactive state and prepared cells for subsequent transcriptional responses. Conclusions Our studies reveal a hitherto unappreciated role for changes in the protein phosphorylation landscape in cellular responses to IFN-I and thus provide insights for novel diagnostic and therapeutic strategies for neurological diseases caused by IFN-I.

The type‐I interferon response potentiates seeded tau aggregation and exacerbates tau pathology

“…First, IFN‐I treatment leads to the upregulation of ISGs, so a single ISG, or a set of ISGs, may be responsible for the increase in seeded tau aggregation. Notably, IFN‐I induces widespread phosphorylation changes in the murine brain, driven by kinase families known to phosphorylate tau 37 . Further, IFN‐I, either through ISGs or JAK/STAT signaling directly, may affect the degradation of tau assemblies entering the cell or following their formation in the seeded tau aggregation process.…”

Scalable ultra-high-throughput single-cell chromatin and RNA sequencing reveals gene regulatory dynamics linking macrophage polarization to autoimmune disease

“…The early STAT1 homodimer response is recapitulated by its phosphorylation pattern: reanalysing data from He et al 35 , we observed that STAT1 becomes phosphorylated at sites T699 and Y701, almost immediately upon IFN-y/LPS stimulation of THP1 derived macrophages, followed by a gradual decrease over time ( Extended Data Figure 6g ). Indeed, phosphorylation of these sites is known to be induced by IFN signaling and trigger accumulation in the nucleus and activation of STAT1 DNA binding activity 36,37 . In contrast to this, the gradual increase in STAT2 and IRF9 activity is reflected by a delayed but sustained increase in the phosphorylation of IRF9 at sites S131 and S253 ( Extended Data Figure 6h ).…”

Analysis of Age-Dependent Transcriptomic Changes in Response to Intracerebral Hemorrhage in Mice

“…A recent RNA-seq analysis between young and aged traumatic brain injury mice reported age-related upregulation of cGAS and type I IFN, which appears to be closely related with microglia-mediated neuroinflammation ( Barrett et al, 2021 ). Except for microglia, astrocytes are the other key players in response to type I IFN according to a proteomics study ( Viengkhou et al, 2021 ). Of interest, previous studies have reported that tPA-induced ICH and traumatic brain injury alter the type I IFN response and STING-mediated type I IFN response, respectively, in mice, thus exacerbating neuroinflammation ( Abdullah et al, 2018 ; Wang et al, 2021 ).…”